Cargando…

Liver Fibrosis Scores and Clinical Outcomes in Patients With COVID-19

BACKGROUND AND AIMS: We investigated the association between liver fibrosis scores and clinical outcomes in patients with COVID-19. METHODS: We performed a post-hoc analysis among patients with COVID-19 from the trial study Outcomes Related to COVID-19 treated with Hydroxychloroquine among Inpatient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Liu, Fuwei, Song, Tiangang, Li, Zhangwang, Xia, Panpan, Tang, Xiaoyi, Xu, Minxuan, Shen, Yunfeng, Ma, Jianyong, Liu, Xiao, Yu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024307/ https://www.ncbi.nlm.nih.gov/pubmed/35463006 http://dx.doi.org/10.3389/fmed.2022.829423

Ejemplares similares

Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19
por: Zhang, Jing, et al.
Publicado: (2022)

Obesity and clinical outcomes in COVID-19 patients without comorbidities, a post-hoc analysis from ORCHID trial
por: Yu, Peng, et al.
Publicado: (2022)

Advances in the study of RNA-binding proteins in diabetic complications
por: Chen, Xinyue, et al.
Publicado: (2022)

O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease
por: Zhou, Yicheng, et al.
Publicado: (2022)

Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis
por: Liu, Fuwei, et al.
Publicado: (2023)

Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis
por: Liu, Menglu, et al.
Publicado: (2022)

Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis
por: Liu, Menglu, et al.
Publicado: (2022)

Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: A systematic review and meta-analysis
por: Tan, Ziqi, et al.
Publicado: (2022)

The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases
por: Wang, Yongbo, et al.
Publicado: (2022)

Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases
por: Cai, Yuxi, et al.
Publicado: (2022)

Therapeutic hypothermia alleviates myocardial ischaemia–reperfusion injury by inhibiting inflammation and fibrosis via the mediation of the SIRT3/NLRP3 signalling pathway
por: Zhang, Jing, et al.
Publicado: (2022)

MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring
por: Xiong, Yiyi, et al.
Publicado: (2022)

Influenza vaccination is associated with a decreased risk of atrial fibrillation: A systematic review and meta-analysis
por: Liu, Menglu, et al.
Publicado: (2022)

The association between liver fibrosis scores and chronic kidney disease
por: Xiong, Shengjun, et al.
Publicado: (2023)

Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
por: Xie, Zhi-Qin, et al.
Publicado: (2021)

Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis
por: Liu, Fuwei, et al.
Publicado: (2021)

Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies
por: Liu, Fuwei, et al.
Publicado: (2021)

Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
por: Park, Huiyul, et al.
Publicado: (2022)

Impact of COPD or Asthma on the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Xue, Zhengbiao, et al.
Publicado: (2022)

Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction
por: Liu, Xiao, et al.
Publicado: (2022)

Association of Coffee Consumption With Atrial Fibrillation Risk: An Updated Dose–Response Meta-Analysis of Prospective Studies
por: Cao, Yalin, et al.
Publicado: (2022)

Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis
por: Oh, Ju Hyun, et al.
Publicado: (2023)

An update on animal models of liver fibrosis
por: Wu, ShuTing, et al.
Publicado: (2023)

Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases
por: Jia, Fuwei, et al.
Publicado: (2022)

Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
por: Qu, Weiyi, et al.
Publicado: (2021)

The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis
por: Ling, Qin, et al.
Publicado: (2023)

Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy
por: Mada, Pradeep Kumar, et al.
Publicado: (2020)

Ferroptosis and ferritinophagy in diabetes complications
por: He, Jiahui, et al.
Publicado: (2022)

Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy
por: Liu, Yupeng, et al.
Publicado: (2023)

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
por: Sun, Qing-Feng, et al.
Publicado: (2022)

Collagen co-localized with macrovesicular steatosis better differentiates fibrosis progression in non-alcoholic fatty liver disease mouse models
por: Wang, Xiao-Xiao, et al.
Publicado: (2023)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
por: Dong, Qingfu, et al.
Publicado: (2023)

Advances in T Cells Based on Inflammation in Metabolic Diseases
por: Yu, Wenlu, et al.
Publicado: (2022)

Potential Effects of Coronaviruses on the Liver: An Update
por: Wang, Xinyi, et al.
Publicado: (2021)

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B
por: Qi, Saiping, et al.
Publicado: (2022)

Interleukin-10 Attenuates Liver Fibrosis Exacerbated by Thermoneutrality
por: Nga, Ha Thi, et al.
Publicado: (2021)

Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
por: Liedtke, Christian, et al.
Publicado: (2022)

Treatment of liver fibrosis in hepatolenticular degeneration with traditional Chinese medicine: systematic review of meta-analysis, network pharmacology and molecular dynamics simulation
por: Yang, Xulong, et al.
Publicado: (2023)

Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity
por: Wu, Cichun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tcelh9p9d1j65tv36qduev3gcb